Sun Pharma

Sun Pharma shares in action on acquisition update of US-based Organon & Co for $11.75 billion

Sun Pharma Share Price: The stock reacted positively to this development, as it is expected to be one of the largest acquisitions by Indian firms overseas.

Sun Pharma Share Price: Stock drops over 4% post Trump's tariffs on branded drugs - Details

Sun Pharma Share Price: Shares of Sun Pharmaceutical Industries Ltd fell nearly 5 per cent to a new 52-week low of Rs 1,547.25 on the BSE.

Sun Pharma Share Price: Stock under pressure, tumbles over 5% following quarterly results

Sun Pharma Share Price: The fall in the shares of the pharma major comes after the company's March quarter (Q3 FY25) results announcement last evening.

Remdesivir shortage in Nagpur; Gadkari dials Sun Pharma chief

Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in Maharashtra.

Lupin, Sun Pharma recall drugs in the US market

Sun Pharma launches Favipiravir in India at Rs 35 per tablet

Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate COVID-19 disease, it added.

Sun Pharma to acquire Canada's Aquinox Pharmaceuticals

Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million.

Sun Pharma gets USFDA nod for plaque psoriasis drug Ilumya

"With the approval of Ilumya and our long-standing commitment in dermatology, we are focused on making a difference for people living with moderate-to-severe plaque psoriasis," Sun Pharma North America president said.

Sun Pharma Q3 profit dips 75% to Rs 365 cr

The drug major had reported net profit of Rs 1,471.82 crore in the October-December quarter of 2016-17.

Sun Pharma to acquire Russian company in Rs 410 crore deal

Drug major Sun Pharmaceutical Industries Ltd has inked a deal to acquire Russian pharma company JSC Biosintez for $24 million (Rs 164 crore). The move will increase Sun Pharma's presence in Russia through local manufacturing

FDA warns Sun Pharma for serious lapses at key manufacturing facility

Mumbai: The US drug regulatory agency, the Food and Drugs Administration (FDA), has warned Sun Pharma, India's biggest drug-manufacturing company, for lapses it observed at its key facility in Halol during an inspection in September

Sun Pharma, Ranbaxy merger finalized, a year after announcement

New Delhi: Sun Pharmaceutical Industries today said that its merger with Ranbaxy has been 'consummated' following receipt of requisite approvals, almost a year it announced the $4 billion deal.In a filing to the BSE, the

Sun Pharma buys GSK's opiates business in Australia

Mumbai: Sun Pharmaceutical Industries has acquired multinational drug maker GlaxoSmithKline's opiates business in Australia. However, the deals of the deal have not been disclosed.GSK's out-going product portfolio consists of poppy-derived opiate raw materials that are

Sun Pharma's Dilip Shanghvi overtakes Mukesh Ambani as the richest Indian

Mumbai: If one goes by the promoter holdings in the companies listed under Bombay Stock Exchange (BSE) then Dilip Shanghvi, the promoter of Sun Pharma will appear to be the richest man in India.With this,

Sun Pharma Q2 net up 15% at Rs 1,572 crore

New Delhi: Sun Pharma on Thursday said its consolidated net profit rose by 15 per cent to Rs 1,572 crore for the second quarter ended September 30.The drug major had posted a net profit of

Sun Pharma rallies over 4%, hits all-time high on strong Taro results

Mumbai: Shares of Sun Pharmaceuticals gained as much as 4.5 per cent in trade on Monday to hit its life-time high of Rs 932, after its subsidiary Taro Pharmaceuticals reported strong set of results for

DRL, Sun Pharma among 14 companies facing price probe in US

Washington: India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers that are being probed by the US Congress over price escalation of generic drugs.In letters sent by Elijah E Cummings (Ranking

Sun Pharma falls 6% on surprise inspection reports

Mumbai: Sun Pharmaceutical Industries slumped as much as 6 percent, heading towards its biggest single-day fall since March 16, 2012.Ranbaxy Laboratories also fell as much as 6 per cent.Media reports say there was a surprise